Idiopathic Pulmonary Fibrosis
Conditions
Interventions
Control Group:Maintain the conventional treatment plan (including dietary management, exercise, and respiratory rehabilitation training, etc.). Take pirfenidone agent.
Sponsors
Xinjiang Uyghur Autonomous Region Uyghur Medical Hospital (Xinjiang Uyghur Autonomous Region Second People's Hospital)
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meets the 2022 ATS/ERS diagnostic criteria for idiopathic pulmonary fibrosis (IPF). (2) Age 40-75 years, pulmonary function: FVC as a percentage of predicted value 50%-80%, DLCO 30%-79%. (3) Patient and family provide informed consent for this study; (4) Patient is able to complete information registration and follow-up as required.
Exclusion criteria
Exclusion criteria: (1) Other known causes of pulmonary fibrosis (e.g., connective tissue diseases, pneumoconiosis). (2) Severe heart, liver, or kidney diseases or active infections. (3) Use of immunosuppressants in the past 3 months or participation in other clinical trials. (4) Pregnant women, breastfeeding women, or women of childbearing age planning pregnancy. (5) Individuals unable to comply with required registration and follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uyghur medicine efficacy evaluation criteria; | — |
Secondary
| Measure | Time frame |
|---|---|
| Transcutaneous oxygen saturation monitoring; | — |
Countries
China
Contacts
Public ContactAman GUL
Xinjiang Uyghur Autonomous Region Uyghur Medical Hospital (Xinjiang Uyghur Autonomous Region Second People's Hospital)
Outcome results
None listed